Baxter International (BAX): Greenhaven Associates Inc added to its stake +3.61M shares
Greenhaven Associates Inc added to its stake in Baxter International, per its Q1 2026 13F.
- 14.3M
- Shares reported · +3.61M vs prior quarter
- 4.0%
- Disclosed portfolio weight
- $240M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- Apr 6, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.8%
- Feb 10, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On February 10, 2026, Baxter International Inc. (the “Company”) appointed Michael R. McDonnell to its Board of Directors (the “Board”), effective February 13, 2026.”
- Mar 15, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 16, 2026, Baxter International Inc. (the “Company”) announced that, as of such date (the “Transition Date”), Joel Grade’s service as Executive Vice President and Chief Financial Officer (“CFO”) of the Company has ceased and, as of such date, Mr. Grade has transitioned into a non-executive officer role and will continue employment with the Company in an advisory capacity through April 30, 2026.”
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 30, 2026FDAFDA drug approval: Epinephrine
- Apr 3, 2026FDAFDA drug approval: Phenylephrine Hydrochloride
What came next
- Apr 15, 2026FDAFDA drug approval: Dexmedetomidine Hydrochloride
- Apr 21, 2026FDARecall: Adapter for Head Positioning, Model/Catalog Number: 1739994, when used in conjunction with the side rails of the Upper Back Section H V U component (product co…
- Apr 21, 20265% stakePZENA INVESTMENT MANAGEMENT LLC reported a passive stake (13G) of 12.7%
- Apr 22, 2026FDARecall: Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Model/Catalog Number: H938175 Product Description: Tubing sets with push-on connector on one end…
- Apr 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 6.4%
- Apr 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.4%
- May 4, 2026Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year (and 1 more item)“On May 4, 2026, the Compensation and Human Capital Committee of the Board of Directors (the “Board”) of Baxter International Inc. (the “Company”) approved the Baxter International Inc. Executive Severance and Change in Control Plan (the “Severance Plan”), effective as of May 4, 2026 (the “Effective Date”).”
- May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 9.0%
- May 21, 2026FDARecall: Hillrom VOLARA System P.CIRCUIT KIT AC (Single Patient Use Circuit), Model/Catalog Number REF M08473; Oscillation Lung Expansion Therapy, positive pressure bre…
- May 21, 2026FDARecall: Hillrom VOLARA System P.CIRCUIT 5KIT AC, (Single Patient Use Circuit), Model/Catalog Number REF M08474; Oscillation Lung Expansion Therapy, positive pressure b…
- May 21, 2026FDARecall: Hillrom VOLARA System P.CIRCUIT KIT (Single Patient Use Circuit), Model/Catalog Number REF M08085; Oscillation Lung Expansion Therapy, positive pressure breath…
- May 21, 2026FDARecall: Hillrom VOLARA P.CIRCUIT 5KIT (System Single Patient Use Circuit), Model/Catalog Number REF M08270; Oscillation Lung Expansion Therapy, positive pressure breat…
- Jun 5, 20265% stakeFMR LLC reported a passive stake (13G) of 10.3%
- Jun 30, 2026FDARecall: Baxter Duo-Vent Solution Set and Male Luer Lock Adapter, Product Code 1C8507; Solution Administration Sets
- Jul 2, 2026FDAFDA drug approval: Levocarnitine
- Jul 8, 2026FDAFDA drug approval: Ephedrine Sulfate
- Jul 24, 2026FDARecall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manu…
- Jul 28, 2026FDAFDA drug approval: Diazepam
- Jul 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Baxter International
For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.
How this filing works
Explore the data
Common questions
What does this filing report about Baxter International (BAX) stock?
Greenhaven Associates Inc added to its stake in Baxter International, per its Q1 2026 13F. Now 14.3M shares, $240M reported value, 4.0% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: Apr 6, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Baxter International recently?
For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BAX page.
Does this mean BAX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Baxter International
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRAug 11, 2026
Everything OQRO holds on this company is on its BAX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
